Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RA
Clinical trial NCT04078191 · TERMINATED
Trial details
- NCT number
- NCT04078191
- Sponsor
- Navidea Biopharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-14
- Primary completion
- 2024-07-09
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.